Ondansetron
Product Images NDC 68071-2865

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ondansetron (NDC 68071-2865). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals,inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

Product Images & Figures Index

FDA Label Image

Pdp (68071 2865 5)

Pdp (68071 2865 5)
NuCare Pharmaceuticals, Inc. manufactures Ondansetron 8mg orally disintegrating tablets. These tablets are packaged in 15 count blister cards with lot number 00000 and expiration date 00-00. The NDC codes are 68071-2865-5 for the tablets and 57237-078-10 for the manufacturer. The tablets contain Ondansetron USP 8mg and are intended for oral consumption. Patients suffering from phenylketonuria should be aware that the tablets contain phenylalanine. Users should call their doctor for medical advice concerning any side effects resulting from use. The FDA can also be contacted at 1-800-FDA-1083. It is essential to keep the medication out of reach of children and to store it at a regulated temperature of 68-77° F.*
FDA Label Image

Chemical Structure (Ondansetronod Str)

Chemical Structure (Ondansetronod Str)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.